Supplemental studies in progress propose that ARV-825 may also be effective in improving the reaction to estrogen deprivation (aromatase inhibition), another component of standard of care in ER+ breast cancer. - "Our study unveiled the crucial purpose in the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in https://abbv-744-combination-ther46891.blog-a-story.com/12516643/not-known-factual-statements-about-abbv-744-preclinical-studies-and-results